Endotherapy Devices Market

The Global Endotherapy Devices Market is valued at USD 4292.4 Million in 2022 and is expected to reach USD 7266.4 Million by 2029 with a CAGR of 7.81% over the forecast period

Global Endotherapy Devices Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2023-2029-  Increasing prevalence of gastrointestinal disorders, and rising number of R & D activities are some of the major factors anticipated to drive the growth of Global Endotherapy Devices Market.

Scope–

The minimally invasive endoscopic techniques are known as "Endotherapy," and the devices used in these procedures are called "Endotherapy devices." Endotherapy devices include the instrument used to create the body opening through which an endoscope or end therapy device is inserted, such as a guide tube, trocar pin, trocar sleeve, or sliding tube. These devices can be used to diagnose chronic pancreatitis, stomach bleeding, abdominal pain, and digestive tract infections. Gastrointestinal (GI) devices & accessories, Endoscopic retrograde chulengo pancreatography (ERCP) devices & accessories are types of the endoscopic devices.

The Covid-19 pandemic has had a mixed impact on the global endotherapy devices market. On one hand, the demand for endotherapy devices has increased due to the growing number of patients with gastrointestinal diseases such as colorectal cancer. On the other hand, the pandemic has led to delays in elective procedures and reduced access to healthcare, which has negatively impacted the market. Additionally, supply chain disruptions and changes in healthcare delivery have also had an impact on the market. However, as the pandemic is brought under control and healthcare systems adapt, the market is expected to recover and grow in the coming years. 

The global endotherapy devices market is segmented on the basis of type, application, end users and region & country level. On the basis of type, the market is segmented into, gastrointestinal (GI) devices & accessories, endoscopic retrograde chulengo pancreatography (ERCP) devices & accessories. On the basis of  application, the market is segmented into laparoscopy, bronchoscopy, arthroscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy and other. On the basis of  end-users, the market is segmented into hospitals,  clinics and others.

The regions covered in global endotherapy devices market report are North America, Europe, Asia-Pacific, Latin America, and Rest of the World. Based on country level, the market of global endotherapy devices market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, Southeast Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

Key Players-

Some of the key players for global endotherapy devices market are -

• Boston Scientific
• Medtronic
• Johnson and Johnson
• Karl Storz
• Hoya
• Smith and Nephew Stryker
• Conmed
• others

Segmentation-

By Type:

• Gastrointestinal (GI) devices & accessories,
• Endoscopic retrograde chulengo pancreatography (ERCP) devices & accessories

By Application:

• Laparoscopy
• Bronchoscopy
• Arthroscopy
• Urology endoscopy
• Neuro-endoscopy
• Gastrointestinal endoscopy
• Other

By End-User:

• Hospitals
• Clinics
• Others

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Increasing Prevalence of Gastrointestinal Disorders, and Rising Number of R & D Activities are Some of the Major Factors Anticipated to Drive the Market Growth

One of the major factors driving the market growth is the growing prevalence of gastrointestinal diseases. Gastrointestinal diseases are those in which the bowel looks abnormal upon examination and also doesn't work properly, and the structural abnormality needs to be removed surgically. The gastrointestinal diseases such as strictures, stenosis, hemorrhoids, diverticular disease, colon polyps, colon cancer, and inflammatory bowel disease have led to a rise in surgical intervention, thereby propelling the demand for minimally invasive treatment incorporating the use of end therapy devices, which is boosting the market growth.

In addition, rising number of R&D activities in this field are also supplementing the market growth. New product launches accompanied by technological advancements in endoscopy therapy devices, such as innovation and improvements in conventional devices, are fueling market growth. For instance; "PowerSpiral," an endoscopy device launched in Europe and parts of the Asia-Pacific region, was announced by Olympus in 2019.

Moreover, the growing demand for minimally invasive procedures is also fueling market growth. The preference for growing minimally invasive procedures is due to numerous applications such as fast recovery, minimal scarring, minor complications, reduced hospital stay, and other advantages which are further fast-tracking the demand for minimally invasive treatments and promoting the adoption of end therapy devices.

However, the high cost of end therapy and lack of skilled endoscopic technicians may hinder the market growth. Despite this, rising investment in this filed many offer more opportunities for the further growth of the growth.

North America id Expected to Dominate the Global Endotherapy Devices Market

North America is expected to dominate the global endotherapy devices market due to its highly developed healthcare system, increasing number of research and development activities, and rising geriatric population in this region. For example; the Centers for Disease Control and Prevention (CDC) predicts that the number of older adults will reach 80.8 million by 2040. In addition, in creasing research and development activities by players are also supplementing the market growth in this region. For example; Boston Scientific Corporation received FDA approval for the Vercise GenusTM Deep Brain Stimulation System in 2021.

Asia Pacific is expected to witness a significant growth in the global endotherapy devices market due to rising technological advancements, increasing government expenditure on healthcare, and growing investments in this field in this region. The market is highly competitive, with several global players competing for market share. One example of a major player in the endotherapy device market in Asia Pacific is Olympus Corporation, a Japanese manufacturer of medical equipment. Another key player in the market is Boston Scientific Corporation, a US-based medical device company that offers a range of endoscopy and endotherapy devices, including endoscopic ultrasound systems, ERCP devices, and stents.

News-

Olympus Announced Complete Line of Single-Use Foreign Body Retrieval Devices added to Endotherapy Portfolio

On December 17^th, 2021; Olympus announced the release of its line of single-use foreign body retrieval devices providing doctors with options for a variety of needs while meeting the demands of infection prevention initiatives. It offers an extensive range of specialized single-use grasping forceps to support in the retrieval of foreign bodies, stents, and excised tissue such as polyps. Olympus is expanding its product portfolio with single-use devices to address procedure-specific requirements and fast access to the greatest tools for the critical  situation.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2022:	USD 4292.4 Million
Base year considered	2021
Forecast Period CAGR %:	7.81%
Market Size Expected in 2029:	USD 7266.4 Million
Tables, Charts & Figures:	175
Pages	300
Key Players/Companies	Boston Scientific , Medtronic, Johnson and Johnson,  Karl Storz, Hoya,  Smith and Nephew Stryker, Conmed and others
Segments Covered	By Type, By End-User, By Application
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa